Lyra Therapeutics News - LYRA

Company Name	Stock Ticker Symbol	Market	Type
Lyra Therapeutics Inc	LYRA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.045	-0.86%	5.185	16:00:42

Open Price	Low Price	High Price	Close Price	Prev Close
5.20	5.13	5.28	5.185	5.23

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/21/2024	16:01	GLOBE	Lyra Therapeutics Reports Fourth Quarter and Full Year 2023..
3/01/2024	16:01	GLOBE	Lyra Therapeutics Announces Inducement Grant Under Nasdaq..
2/15/2024	09:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	20:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	18:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:51	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	16:34	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/01/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/01/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	06:13	EDGAR2	Form 8-K - Current report
12/28/2023	06:40	EDGAR2	Form 8-K - Current report
12/18/2023	16:16	EDGAR2	Form 8-K - Current report
11/16/2023	17:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/13/2023	17:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/07/2023	16:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:09	EDGAR2	Form 8-K - Current report
11/07/2023	16:01	GLOBE	Lyra Therapeutics Reports Third Quarter 2023 Financial..
11/07/2023	07:00	GLOBE	Lyra Therapeutics to Participate in Upcoming Investor..
10/16/2023	07:00	GLOBE	Lyra Therapeutics Announces Appointment of Ronan O’Brien as..
9/12/2023	16:01	EDGAR2	Form 8-K - Current report
9/12/2023	07:00	GLOBE	Lyra Therapeutics Announces Positive Topline Results from..
9/06/2023	08:00	GLOBE	Lyra Therapeutics to Participate in Upcoming Investor..
9/01/2023	16:03	EDGAR2	Form 8-K - Current report
9/01/2023	16:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/29/2023	07:00	GLOBE	Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I..
8/25/2023	16:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/08/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:03	EDGAR2	Form 8-K - Current report
8/08/2023	16:01	GLOBE	Lyra Therapeutics Reports Second Quarter 2023 Financial..
7/14/2023	16:06	EDGAR2	Form 8-K - Current report
7/13/2023	07:30	GLOBE	Lyra Therapeutics to Present at William Blair Virtual..
7/12/2023	18:36	EDGAR2	Form 4/A - Statement of changes in beneficial ownership of..
7/07/2023	16:44	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
7/05/2023	21:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	21:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	21:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	16:06	EDGAR2	Form S-3 - Registration statement under Securities Act of..
6/02/2023	16:01	GLOBE	Lyra Therapeutics Announces Inducement Grant Under Nasdaq..
6/02/2023	07:30	GLOBE	Lyra Therapeutics to Present at Jefferies Healthcare..
6/01/2023	07:29	GLOBE	Lyra Therapeutics Announces Closing of $50.0 Million Private..
5/26/2023	07:57	GLOBE	Lyra Therapeutics Announces $50.0 Million Private Placement
5/12/2023	07:00	GLOBE	Lyra Therapeutics Reports First Quarter 2023 Financial..
5/09/2023	16:01	GLOBE	Lyra Therapeutics to Present at Bank of America Securities..